Our Company was originally incorporated as "Aptus Pharma Private Limited" as a private limited company under the provisions of the Companies Act, 1956 pursuant to a Certificate of Incorporation dated August 12, 2010, issued by the Registrar of Companies, Gujarat. Subsequently, our Company was converted into a public limited company in accordance with the provisions of the Companies Act, 2013, pursuant to a special resolution passed by the shareholders in their extraordinary general meeting held on November 30, 2024. A fresh Certificate of Incorporation consequent upon such conversion was issued by the Registrar of Companies, Central Processing Centre, on December 12, 2024, and the name of our Company was changed to "Aptus Pharma Limited." The Corporate Identification Number of our Company is U24230GJ2010PLC061957.MAJOR EVENTS:2010- Incorporation of our company under the name "Aptus Pharma Private Limited"2011-2013- Commenced operations through four regional headquarters in Gujarat. Launched a portfolio of 25 products targeting essential therapeutic segments.2013-2016- Achieved approximately 33% geographical coverage in Gujarat. Expanded product portfolio to over 50 products, catering to both acute and chronic segments.2016-2019- Increased portfolio to over 70 products in response to evolving therapeutic requirements.2019-2022- Extended presence to around 80% of Gujarat, including remote areas. Product portfolio grew to over 100 products. Appointed a C&F agent in Ahmedabad and improved logistics infrastructure.2022-2024- Achieved full geographical coverage across Gujarat. Expanded product portfolio to over 175 products. Established three operational divisions: Acute, Chronic, and OTC. Initiated in-house manufacturing under a loan license arrangement.2024- Converted to a public limited company and changed name to "Aptus Pharma Limited".